Stockreport

Foghorn Therapeutics to Participate at the Evercore ISI HealthCONx Conference

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical stage biotechnology company pioneering a new class of medicin [Read more]